Management of venous thromboembolism in colorectal cancer patients treated with bevacizumab View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2009-08-21

AUTHORS

Mitsukuni Suenaga, Nobuyuki Mizunuma, Kokoro Kobayashi, Eiji Shinozaki, Satoshi Matsusaka, Keisho Chin, Yasutoshi Kuboki, Takashi Ichimura, Masato Ozaka, Mariko Ogura, Yoshimasa Fujiwara, Kiyoshi Matsueda, Fumio Konishi, Kiyohiko Hatake

ABSTRACT

Venous thromboembolism associated with use of a central venous access system is an urgent problem in patients treated with bevacizumab (bev). We investigated the effectiveness of Doppler ultrasound imaging (DUS) in the early detection of catheter-related thrombosis for avoidance of severe venous thromboembolism. Patients with metastatic colorectal cancer received either FOLFOX-4 + bev or FOLFIRI + bev. DUS was performed on the deep venous system for detection of thrombus formation during the initial cycle of treatment, followed by re-evaluation after the third cycle in patients with asymptomatic thrombus formation. All patients were followed up until treatment was interrupted. Median duration of follow-up was 484 days (range 72–574). Among 41 enrolled patients, curable symptomatic thrombosis occurred in one, and asymptomatic thrombosis in 21 (51.2%). Of 21 patients undergoing re-evaluation, thrombi remained without progression in 17 patients, and enlargement in 4 patients. In two of the patients in whom there was progression, pulmonary embolism occurred after the sixth cycle. In the asymptomatic group, no thrombi developed as far as the superior vena cava in any patient. In the cases of progression, thrombotic enlargement was observed in all the 4 patients, with decreased vascular flow in 2. Using DUS, we were able to detect asymptomatic thrombosis in the early cycles of treatment, indicating its potential in the monitoring of venous thrombi. In the event of an enlarging asymptomatic thrombosis developing into the superior vena cava along with decreased vascular flow, careful follow-up and appropriate anticoagulant therapy may be recommended without increased risk of bleeding. More... »

PAGES

807-814

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12032-009-9289-6

DOI

http://dx.doi.org/10.1007/s12032-009-9289-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1043380802

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/19697164


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adenocarcinoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Angiogenesis Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal, Humanized", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anticoagulants", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bevacizumab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Camptothecin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Catheterization, Central Venous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Colorectal Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Progression", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Early Diagnosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorouracil", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leucovorin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Organoplatinum Compounds", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pulmonary Embolism", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thrombophilia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ultrasonography, Doppler", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vena Cava, Superior", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Venous Thromboembolism", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410807.a", 
          "name": [
            "Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Suenaga", 
        "givenName": "Mitsukuni", 
        "id": "sg:person.01024665203.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024665203.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410807.a", 
          "name": [
            "Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mizunuma", 
        "givenName": "Nobuyuki", 
        "id": "sg:person.01357134113.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357134113.91"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410807.a", 
          "name": [
            "Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kobayashi", 
        "givenName": "Kokoro", 
        "id": "sg:person.01217256521.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01217256521.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410807.a", 
          "name": [
            "Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shinozaki", 
        "givenName": "Eiji", 
        "id": "sg:person.01145664051.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145664051.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410807.a", 
          "name": [
            "Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Matsusaka", 
        "givenName": "Satoshi", 
        "id": "sg:person.01125517543.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125517543.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410807.a", 
          "name": [
            "Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chin", 
        "givenName": "Keisho", 
        "id": "sg:person.01042133603.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042133603.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410807.a", 
          "name": [
            "Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kuboki", 
        "givenName": "Yasutoshi", 
        "id": "sg:person.01247112675.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01247112675.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410807.a", 
          "name": [
            "Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ichimura", 
        "givenName": "Takashi", 
        "id": "sg:person.013421707227.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013421707227.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410807.a", 
          "name": [
            "Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ozaka", 
        "givenName": "Masato", 
        "id": "sg:person.01123136152.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123136152.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410807.a", 
          "name": [
            "Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ogura", 
        "givenName": "Mariko", 
        "id": "sg:person.0611456603.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0611456603.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410807.a", 
          "name": [
            "Department of Radiology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fujiwara", 
        "givenName": "Yoshimasa", 
        "id": "sg:person.01344511367.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01344511367.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410807.a", 
          "name": [
            "Department of Radiology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Matsueda", 
        "givenName": "Kiyoshi", 
        "id": "sg:person.01300441324.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01300441324.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Omiya Medical Center, Jichi Medical University, 330-8503, Amanuma cho, Omiya-ku, Saitama City, Saitama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415020.2", 
          "name": [
            "Department of Surgery, Omiya Medical Center, Jichi Medical University, 330-8503, Amanuma cho, Omiya-ku, Saitama City, Saitama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Konishi", 
        "givenName": "Fumio", 
        "id": "sg:person.01272216415.22", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272216415.22"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410807.a", 
          "name": [
            "Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hatake", 
        "givenName": "Kiyohiko", 
        "id": "sg:person.01252161657.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252161657.78"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00366902", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031504592", 
          "https://doi.org/10.1007/bf00366902"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2009-08-21", 
    "datePublishedReg": "2009-08-21", 
    "description": "Venous thromboembolism associated with use of a central venous access system is an urgent problem in patients treated with bevacizumab (bev). We investigated the effectiveness of Doppler ultrasound imaging (DUS) in the early detection of catheter-related thrombosis for avoidance of severe venous thromboembolism. Patients with metastatic colorectal cancer received either FOLFOX-4\u00a0+\u00a0bev or FOLFIRI\u00a0+\u00a0bev. DUS was performed on the deep venous system for detection of thrombus formation during the initial cycle of treatment, followed by re-evaluation after the third cycle in patients with asymptomatic thrombus formation. All patients were followed up until treatment was interrupted. Median duration of follow-up was 484\u00a0days (range 72\u2013574). Among 41 enrolled patients, curable symptomatic thrombosis occurred in one, and asymptomatic thrombosis in 21 (51.2%). Of 21 patients undergoing re-evaluation, thrombi remained without progression in 17 patients, and enlargement in 4 patients. In two of the patients in whom there was progression, pulmonary embolism occurred after the sixth cycle. In the asymptomatic group, no thrombi developed as far as the superior vena cava in any patient. In the cases of progression, thrombotic enlargement was observed in all the 4 patients, with decreased vascular flow in 2. Using DUS, we were able to detect asymptomatic thrombosis in the early cycles of treatment, indicating its potential in the monitoring of venous thrombi. In the event of an enlarging asymptomatic thrombosis developing into the superior vena cava along with decreased vascular flow, careful follow-up and appropriate anticoagulant therapy may be recommended without increased risk of bleeding.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s12032-009-9289-6", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1094524", 
        "issn": [
          "1357-0560", 
          "1559-131X"
        ], 
        "name": "Medical Oncology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "27"
      }
    ], 
    "keywords": [
      "superior vena cava", 
      "asymptomatic thrombosis", 
      "venous thromboembolism", 
      "Doppler ultrasound imaging", 
      "vena cava", 
      "thrombus formation", 
      "vascular flow", 
      "central venous access systems", 
      "catheter-related thrombosis", 
      "severe venous thromboembolism", 
      "appropriate anticoagulant therapy", 
      "metastatic colorectal cancer", 
      "venous access system", 
      "case of progression", 
      "colorectal cancer patients", 
      "deep venous system", 
      "symptomatic thrombosis", 
      "FOLFOX-4", 
      "median duration", 
      "anticoagulant therapy", 
      "pulmonary embolism", 
      "asymptomatic group", 
      "colorectal cancer", 
      "venous thrombi", 
      "cancer patients", 
      "venous system", 
      "patients", 
      "thrombosis", 
      "thromboembolism", 
      "early detection", 
      "progression", 
      "bevacizumab", 
      "cava", 
      "thrombus", 
      "treatment", 
      "sixth cycle", 
      "ultrasound imaging", 
      "enlargement", 
      "third cycle", 
      "FOLFIRI", 
      "embolism", 
      "therapy", 
      "cancer", 
      "risk", 
      "duration", 
      "days", 
      "imaging", 
      "group", 
      "management", 
      "cases", 
      "detection", 
      "cycle", 
      "events", 
      "avoidance", 
      "initial cycle", 
      "monitoring", 
      "use", 
      "early cycles", 
      "effectiveness", 
      "potential", 
      "formation", 
      "flow", 
      "system", 
      "urgent problem", 
      "problem", 
      "access system"
    ], 
    "name": "Management of venous thromboembolism in colorectal cancer patients treated with bevacizumab", 
    "pagination": "807-814", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1043380802"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12032-009-9289-6"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "19697164"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12032-009-9289-6", 
      "https://app.dimensions.ai/details/publication/pub.1043380802"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:26", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_498.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s12032-009-9289-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12032-009-9289-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12032-009-9289-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12032-009-9289-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12032-009-9289-6'


 

This table displays all metadata directly associated to this object as RDF triples.

352 TRIPLES      22 PREDICATES      124 URIs      115 LITERALS      38 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12032-009-9289-6 schema:about N05ed57887ae94c6993b4ef8190f0cf7c
2 N091ce25fd5eb49dda19fe5d99143cc2b
3 N0b1492293daa46c190098bc09ee01c47
4 N12a56065e8574c49af8fd2f1eea7b0fa
5 N298580d8ebb244698e1c691cc3dced22
6 N30b2aea789ca4071bf225a0f68004865
7 N4707525b98934ad593e37e932e2646e7
8 N4761d89b908d4e0d8bfaf57b93a5b952
9 N47992ba310d241c8a05ca8ed3ebbe2ee
10 N4c1763b1201e420cbd107ab20dbbf145
11 N53f90d3abe9c412f90f092863e6d9137
12 N5b08e76e4b3c495d9c32425cc75ec55a
13 N6898fb35b3334d19995e4a816c9c979f
14 N6e471ddadc2d4f959db2d75f3fcda601
15 N6f8d0203299d4b82ba48f3365fcfdfb3
16 N7aad94b6d03843368b8ce7306e92b17e
17 N7b80ba488275443c90e4f2f0778a4450
18 N7e8a88b5006f4cd4a632d62ba6dd55b4
19 N8bd20a1263da45cb873608f527fc8a19
20 N8cb4fcf105854ada829ce03f8d8795ec
21 Na606121418d741349ca626ad5daa6eed
22 Nabd36533a31042438d3c50500642284e
23 Nbe2b1b21e85d432fbb092dcdd0ebc15d
24 Nc099b65dab5f469fb6274651ad545395
25 Nc0b9b40c8a7a4b14a4ed0e7ec7dc1062
26 Nc3c86b8691f045379019bc4f4eb32c49
27 Nc83359711acb4dd091fa8d5a2becb055
28 Nccd96d5cbf394bc99b709c21c7428efc
29 Nebf2f4340f1d4465b885cc0030a2b238
30 Nf008593607f44b2796b3d25160657751
31 Nfa247d4ba1a24bcb8aba9733feb5b9e7
32 anzsrc-for:11
33 anzsrc-for:1112
34 schema:author N307a070c398c49fc841b32de2c89ae82
35 schema:citation sg:pub.10.1007/bf00366902
36 schema:datePublished 2009-08-21
37 schema:datePublishedReg 2009-08-21
38 schema:description Venous thromboembolism associated with use of a central venous access system is an urgent problem in patients treated with bevacizumab (bev). We investigated the effectiveness of Doppler ultrasound imaging (DUS) in the early detection of catheter-related thrombosis for avoidance of severe venous thromboembolism. Patients with metastatic colorectal cancer received either FOLFOX-4 + bev or FOLFIRI + bev. DUS was performed on the deep venous system for detection of thrombus formation during the initial cycle of treatment, followed by re-evaluation after the third cycle in patients with asymptomatic thrombus formation. All patients were followed up until treatment was interrupted. Median duration of follow-up was 484 days (range 72–574). Among 41 enrolled patients, curable symptomatic thrombosis occurred in one, and asymptomatic thrombosis in 21 (51.2%). Of 21 patients undergoing re-evaluation, thrombi remained without progression in 17 patients, and enlargement in 4 patients. In two of the patients in whom there was progression, pulmonary embolism occurred after the sixth cycle. In the asymptomatic group, no thrombi developed as far as the superior vena cava in any patient. In the cases of progression, thrombotic enlargement was observed in all the 4 patients, with decreased vascular flow in 2. Using DUS, we were able to detect asymptomatic thrombosis in the early cycles of treatment, indicating its potential in the monitoring of venous thrombi. In the event of an enlarging asymptomatic thrombosis developing into the superior vena cava along with decreased vascular flow, careful follow-up and appropriate anticoagulant therapy may be recommended without increased risk of bleeding.
39 schema:genre article
40 schema:inLanguage en
41 schema:isAccessibleForFree false
42 schema:isPartOf N41002356a15e4bf9880d4b14793dbc27
43 Nf070056b34db4738aa75b1e062c7256c
44 sg:journal.1094524
45 schema:keywords Doppler ultrasound imaging
46 FOLFIRI
47 FOLFOX-4
48 access system
49 anticoagulant therapy
50 appropriate anticoagulant therapy
51 asymptomatic group
52 asymptomatic thrombosis
53 avoidance
54 bevacizumab
55 cancer
56 cancer patients
57 case of progression
58 cases
59 catheter-related thrombosis
60 cava
61 central venous access systems
62 colorectal cancer
63 colorectal cancer patients
64 cycle
65 days
66 deep venous system
67 detection
68 duration
69 early cycles
70 early detection
71 effectiveness
72 embolism
73 enlargement
74 events
75 flow
76 formation
77 group
78 imaging
79 initial cycle
80 management
81 median duration
82 metastatic colorectal cancer
83 monitoring
84 patients
85 potential
86 problem
87 progression
88 pulmonary embolism
89 risk
90 severe venous thromboembolism
91 sixth cycle
92 superior vena cava
93 symptomatic thrombosis
94 system
95 therapy
96 third cycle
97 thromboembolism
98 thrombosis
99 thrombus
100 thrombus formation
101 treatment
102 ultrasound imaging
103 urgent problem
104 use
105 vascular flow
106 vena cava
107 venous access system
108 venous system
109 venous thrombi
110 venous thromboembolism
111 schema:name Management of venous thromboembolism in colorectal cancer patients treated with bevacizumab
112 schema:pagination 807-814
113 schema:productId N568cd680f5f147abbb14df1aa0ef9f3d
114 N8c0ead4fb80b4fb29f7645c8ec67a1fc
115 N8fab626c64dd44c3ba05818b5cd3fe39
116 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043380802
117 https://doi.org/10.1007/s12032-009-9289-6
118 schema:sdDatePublished 2022-05-20T07:26
119 schema:sdLicense https://scigraph.springernature.com/explorer/license/
120 schema:sdPublisher N30ff74e9293b450ba51e6f6e9ffbff32
121 schema:url https://doi.org/10.1007/s12032-009-9289-6
122 sgo:license sg:explorer/license/
123 sgo:sdDataset articles
124 rdf:type schema:ScholarlyArticle
125 N05ed57887ae94c6993b4ef8190f0cf7c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Middle Aged
127 rdf:type schema:DefinedTerm
128 N091ce25fd5eb49dda19fe5d99143cc2b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Colorectal Neoplasms
130 rdf:type schema:DefinedTerm
131 N0b1492293daa46c190098bc09ee01c47 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Pulmonary Embolism
133 rdf:type schema:DefinedTerm
134 N12a56065e8574c49af8fd2f1eea7b0fa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Leucovorin
136 rdf:type schema:DefinedTerm
137 N15de410847004927a9b897d6dcf2577d rdf:first sg:person.013421707227.10
138 rdf:rest N87b18453f144472e8ed00ec887c54786
139 N23a4ff8ef92546e9957a234b9e1885ae rdf:first sg:person.0611456603.36
140 rdf:rest Necdd992d17974fd1ab45b9239e567f01
141 N298580d8ebb244698e1c691cc3dced22 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Humans
143 rdf:type schema:DefinedTerm
144 N2df7e356f26b4f04b2d4f4eefcb5d967 rdf:first sg:person.01252161657.78
145 rdf:rest rdf:nil
146 N307a070c398c49fc841b32de2c89ae82 rdf:first sg:person.01024665203.77
147 rdf:rest N68f05793359b40ba938cce3b162e819f
148 N30b2aea789ca4071bf225a0f68004865 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Ultrasonography, Doppler
150 rdf:type schema:DefinedTerm
151 N30ff74e9293b450ba51e6f6e9ffbff32 schema:name Springer Nature - SN SciGraph project
152 rdf:type schema:Organization
153 N41002356a15e4bf9880d4b14793dbc27 schema:issueNumber 3
154 rdf:type schema:PublicationIssue
155 N4321cb5e6d984215ba666ff9ed140959 rdf:first sg:person.01217256521.67
156 rdf:rest N954fdef8c8c345aea3f9b36b178a555a
157 N4707525b98934ad593e37e932e2646e7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Early Diagnosis
159 rdf:type schema:DefinedTerm
160 N4761d89b908d4e0d8bfaf57b93a5b952 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Anticoagulants
162 rdf:type schema:DefinedTerm
163 N47992ba310d241c8a05ca8ed3ebbe2ee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Antibodies, Monoclonal
165 rdf:type schema:DefinedTerm
166 N4c1763b1201e420cbd107ab20dbbf145 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Adenocarcinoma
168 rdf:type schema:DefinedTerm
169 N4dbee9ef5547481b8f423352d93fdac0 rdf:first sg:person.01247112675.07
170 rdf:rest N15de410847004927a9b897d6dcf2577d
171 N53f90d3abe9c412f90f092863e6d9137 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Thrombophilia
173 rdf:type schema:DefinedTerm
174 N568cd680f5f147abbb14df1aa0ef9f3d schema:name pubmed_id
175 schema:value 19697164
176 rdf:type schema:PropertyValue
177 N5a1947d56969462db24a5881450ea356 rdf:first sg:person.01042133603.45
178 rdf:rest N4dbee9ef5547481b8f423352d93fdac0
179 N5b08e76e4b3c495d9c32425cc75ec55a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Adolescent
181 rdf:type schema:DefinedTerm
182 N6898fb35b3334d19995e4a816c9c979f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Organoplatinum Compounds
184 rdf:type schema:DefinedTerm
185 N68f05793359b40ba938cce3b162e819f rdf:first sg:person.01357134113.91
186 rdf:rest N4321cb5e6d984215ba666ff9ed140959
187 N6e471ddadc2d4f959db2d75f3fcda601 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Risk Factors
189 rdf:type schema:DefinedTerm
190 N6f8d0203299d4b82ba48f3365fcfdfb3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Angiogenesis Inhibitors
192 rdf:type schema:DefinedTerm
193 N7aad94b6d03843368b8ce7306e92b17e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Follow-Up Studies
195 rdf:type schema:DefinedTerm
196 N7b80ba488275443c90e4f2f0778a4450 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
197 schema:name Antineoplastic Combined Chemotherapy Protocols
198 rdf:type schema:DefinedTerm
199 N7e8a88b5006f4cd4a632d62ba6dd55b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
200 schema:name Prospective Studies
201 rdf:type schema:DefinedTerm
202 N87b18453f144472e8ed00ec887c54786 rdf:first sg:person.01123136152.11
203 rdf:rest N23a4ff8ef92546e9957a234b9e1885ae
204 N8bd20a1263da45cb873608f527fc8a19 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
205 schema:name Venous Thromboembolism
206 rdf:type schema:DefinedTerm
207 N8c0ead4fb80b4fb29f7645c8ec67a1fc schema:name dimensions_id
208 schema:value pub.1043380802
209 rdf:type schema:PropertyValue
210 N8cb4fcf105854ada829ce03f8d8795ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
211 schema:name Antibodies, Monoclonal, Humanized
212 rdf:type schema:DefinedTerm
213 N8fab626c64dd44c3ba05818b5cd3fe39 schema:name doi
214 schema:value 10.1007/s12032-009-9289-6
215 rdf:type schema:PropertyValue
216 N954fdef8c8c345aea3f9b36b178a555a rdf:first sg:person.01145664051.07
217 rdf:rest Ndc57835135f64bb1881550c51edd731d
218 N9d0244fb3fb34bbb842e8c36679441e7 rdf:first sg:person.01272216415.22
219 rdf:rest N2df7e356f26b4f04b2d4f4eefcb5d967
220 Na606121418d741349ca626ad5daa6eed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
221 schema:name Adult
222 rdf:type schema:DefinedTerm
223 Nabd36533a31042438d3c50500642284e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
224 schema:name Male
225 rdf:type schema:DefinedTerm
226 Nbe2b1b21e85d432fbb092dcdd0ebc15d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
227 schema:name Young Adult
228 rdf:type schema:DefinedTerm
229 Nc099b65dab5f469fb6274651ad545395 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
230 schema:name Vena Cava, Superior
231 rdf:type schema:DefinedTerm
232 Nc0b9b40c8a7a4b14a4ed0e7ec7dc1062 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
233 schema:name Camptothecin
234 rdf:type schema:DefinedTerm
235 Nc3c86b8691f045379019bc4f4eb32c49 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
236 schema:name Bevacizumab
237 rdf:type schema:DefinedTerm
238 Nc83359711acb4dd091fa8d5a2becb055 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
239 schema:name Fluorouracil
240 rdf:type schema:DefinedTerm
241 Nccd96d5cbf394bc99b709c21c7428efc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
242 schema:name Female
243 rdf:type schema:DefinedTerm
244 Ncf9d7fb3dfbb436894e65c7aa4d9f079 rdf:first sg:person.01300441324.46
245 rdf:rest N9d0244fb3fb34bbb842e8c36679441e7
246 Ndc57835135f64bb1881550c51edd731d rdf:first sg:person.01125517543.23
247 rdf:rest N5a1947d56969462db24a5881450ea356
248 Nebf2f4340f1d4465b885cc0030a2b238 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
249 schema:name Disease Progression
250 rdf:type schema:DefinedTerm
251 Necdd992d17974fd1ab45b9239e567f01 rdf:first sg:person.01344511367.43
252 rdf:rest Ncf9d7fb3dfbb436894e65c7aa4d9f079
253 Nf008593607f44b2796b3d25160657751 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
254 schema:name Catheterization, Central Venous
255 rdf:type schema:DefinedTerm
256 Nf070056b34db4738aa75b1e062c7256c schema:volumeNumber 27
257 rdf:type schema:PublicationVolume
258 Nfa247d4ba1a24bcb8aba9733feb5b9e7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
259 schema:name Aged
260 rdf:type schema:DefinedTerm
261 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
262 schema:name Medical and Health Sciences
263 rdf:type schema:DefinedTerm
264 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
265 schema:name Oncology and Carcinogenesis
266 rdf:type schema:DefinedTerm
267 sg:journal.1094524 schema:issn 1357-0560
268 1559-131X
269 schema:name Medical Oncology
270 schema:publisher Springer Nature
271 rdf:type schema:Periodical
272 sg:person.01024665203.77 schema:affiliation grid-institutes:grid.410807.a
273 schema:familyName Suenaga
274 schema:givenName Mitsukuni
275 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024665203.77
276 rdf:type schema:Person
277 sg:person.01042133603.45 schema:affiliation grid-institutes:grid.410807.a
278 schema:familyName Chin
279 schema:givenName Keisho
280 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042133603.45
281 rdf:type schema:Person
282 sg:person.01123136152.11 schema:affiliation grid-institutes:grid.410807.a
283 schema:familyName Ozaka
284 schema:givenName Masato
285 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123136152.11
286 rdf:type schema:Person
287 sg:person.01125517543.23 schema:affiliation grid-institutes:grid.410807.a
288 schema:familyName Matsusaka
289 schema:givenName Satoshi
290 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125517543.23
291 rdf:type schema:Person
292 sg:person.01145664051.07 schema:affiliation grid-institutes:grid.410807.a
293 schema:familyName Shinozaki
294 schema:givenName Eiji
295 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145664051.07
296 rdf:type schema:Person
297 sg:person.01217256521.67 schema:affiliation grid-institutes:grid.410807.a
298 schema:familyName Kobayashi
299 schema:givenName Kokoro
300 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01217256521.67
301 rdf:type schema:Person
302 sg:person.01247112675.07 schema:affiliation grid-institutes:grid.410807.a
303 schema:familyName Kuboki
304 schema:givenName Yasutoshi
305 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01247112675.07
306 rdf:type schema:Person
307 sg:person.01252161657.78 schema:affiliation grid-institutes:grid.410807.a
308 schema:familyName Hatake
309 schema:givenName Kiyohiko
310 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252161657.78
311 rdf:type schema:Person
312 sg:person.01272216415.22 schema:affiliation grid-institutes:grid.415020.2
313 schema:familyName Konishi
314 schema:givenName Fumio
315 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272216415.22
316 rdf:type schema:Person
317 sg:person.01300441324.46 schema:affiliation grid-institutes:grid.410807.a
318 schema:familyName Matsueda
319 schema:givenName Kiyoshi
320 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01300441324.46
321 rdf:type schema:Person
322 sg:person.013421707227.10 schema:affiliation grid-institutes:grid.410807.a
323 schema:familyName Ichimura
324 schema:givenName Takashi
325 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013421707227.10
326 rdf:type schema:Person
327 sg:person.01344511367.43 schema:affiliation grid-institutes:grid.410807.a
328 schema:familyName Fujiwara
329 schema:givenName Yoshimasa
330 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01344511367.43
331 rdf:type schema:Person
332 sg:person.01357134113.91 schema:affiliation grid-institutes:grid.410807.a
333 schema:familyName Mizunuma
334 schema:givenName Nobuyuki
335 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357134113.91
336 rdf:type schema:Person
337 sg:person.0611456603.36 schema:affiliation grid-institutes:grid.410807.a
338 schema:familyName Ogura
339 schema:givenName Mariko
340 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0611456603.36
341 rdf:type schema:Person
342 sg:pub.10.1007/bf00366902 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031504592
343 https://doi.org/10.1007/bf00366902
344 rdf:type schema:CreativeWork
345 grid-institutes:grid.410807.a schema:alternateName Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan
346 Department of Radiology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan
347 schema:name Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan
348 Department of Radiology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, 135-8550, Tokyo, Japan
349 rdf:type schema:Organization
350 grid-institutes:grid.415020.2 schema:alternateName Department of Surgery, Omiya Medical Center, Jichi Medical University, 330-8503, Amanuma cho, Omiya-ku, Saitama City, Saitama, Japan
351 schema:name Department of Surgery, Omiya Medical Center, Jichi Medical University, 330-8503, Amanuma cho, Omiya-ku, Saitama City, Saitama, Japan
352 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...